Answer
Nivolumab (OPDIVO), alone or with ipilimumab, is indicated for advanced unresectable or metastatic melanoma in adults and adolescents aged 12 years and older.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 67Document updated
Sources checked